NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31

Nuvation Bio Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$4.48+0.03 (+0.67%)

Close on Oct 19, 2026

Market cap: $1.56M
P/E (TTM): –
Dividend yield: –

Nuvation Bio Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Revenue	63	7.87	0	–	–	–
Cost of Revenue	–	7.08	0	–	–	–
Gross Profit	–	0.80	0	–	–	–
Research & Development	115	99	71	88	69	33
Selling, General & Admin	152	69	29	–	–	–
General & Administrative	–	–	29	32	24	11
Operating Expenses	276	601	100	120	93	44
Operating Income	-213	-593	-100	-120	-93	-44
Interest Expense	14	0.34	0	–	–	–
Interest & Investment Income	21	27	25	7.45	2.96	1.95
Other Non-Operating Income	8.44	25	24	16	6.47	1.89
Merger & Restructuring Charges	–	–	–	7.40	–	–
Gain (Loss) on Investments	–	–	0	-0.17	-0.17	0.22
Gain (Loss) on Sale of Assets	-0.03	0	-0.01	-0.05	0	–
Pretax Income	-205	-568	-76	-104	-87	-42
Income Tax Expense	0	0	0	0	0	0
Net Income	-205	-568	-76	-104	-87	-42
EPS (Basic)(per share)	-0.60	-2.11	-0.35	-0.48	-0.44	-0.43
EPS (Diluted)(per share)	-0.60	-2.11	-0.35	-0.48	-0.44	-0.43
Shares Outstanding (Basic, Weighted)(shares)	0.34	0.27	0.22	0.22	0.20	98
Shares Outstanding (Diluted, Weighted)(shares)	0.34	0.27	0.22	0.22	0.20	98
EBITDA	-211	-592	-100	-120	-93	-43

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -81.0%
Net margin: -88.2%
Return on equity, FY2025: -53.2%

Financial strength

Current ratio: 8.37
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 298.1%

Valuation

P/E ratio: –
Price to sales: 0.01
Price to book: 0.01
Dividend yield: –